BIIB033 (also known as Anti-LINGO-1) is a monoclonal antibody targeting LINGO1. It is currently being developed by Biogen as a treatment for diseases such as multiple sclerosis and optic neuritis.
References
BIIB033 Wikipedia(Text) CC BY-SA
BIIB033
Updated on
Edit
Like
Comment
Similar Topics